Beckman Coulter#s Automated Microplate System Provides High-Volume Laboratories with Unmatched Throughput for Donor Blood Testing

Food and Healthcare Press Releases Thursday January 31, 2019 08:55
BREA, California--31 Jan--PRNewswire/InfoQuest
  • The new PK7400 leverages Beckman Coulter's more than 30-year customer proven reliability, accuracy and workload capacity

Beckman Coulter, a global leader in the clinical diagnostics industry, announced today the launch of its next-generation fully automated microplate system for donor blood testing, the PK7400. Designed for use in blood donor centers, plasma centers and large reference laboratories, the new system offers the industry's highest throughput, processing the greatest volume of samples for a single analyzer in its class – up to 300 samples per hour.

"Customers have relied on our PK systems for more than 30 years to deliver the quality results and workload capacity they have come to expect from Beckman Coulter," said Puneet Sarin, senior vice president and general manager for Beckman Coulter's chemistry and immunoassay business. "We designed the PK7400 to further that legacy by providing donor laboratory professionals with the reliability and workflow they need to improve staff efficiency."

The new PK7400 system also provides the ability to test multiple assays in a single batch without affecting the throughput. The assay menu includes ABO blood grouping, Rh typing, weak D testing, red blood cell antigen screening as well as syphilis qualitative screening**. Backed by Beckman Coulter's PROService tool, the PK7400 also facilitates real-time monitoring that helps to improve laboratory system uptime and reduce service visits.

Beckman Coulter's commitment to moving healthcare forward includes providing laboratory professionals with superior workflow solutions to help minimize laboratory workload. The PK7400 was designed with specific workflow enhancements including easier-to-load supplies and improved visual instrument status. These research and development advancements reinforce Beckman Coulter's ongoing mission to bringing innovative solutions to the diagnostics industry.

For more information on the PK7400, visit
About Beckman Coulter Diagnostics

Beckman Coulter Diagnostics helps healthcare and laboratory professionals provide better patient care by delivering the accurate diagnostic information they need, when they need it. With a rich 80-year history, Beckman Coulter is a strong partner for healthcare organizations. Our scalable instruments, comprehensive diagnostic tests and business management services are trusted by hospitals, laboratories and other critical care settings around the world. We share in our customers' mission toward continuous improvement and quality patient care because we believe when efficiency and clinical outcomes are improved, patients benefit and we can move healthcare forward for every person.

*Product availability and regulatory status depends on country registration per applicable regulations.
**Not all assays are available in all markets.

(C) 2019 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Photo -
Logo -

Latest Press Release

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins. The acquisition includes...

Pneuma Respiratory, Inc. Announces New Chairman of the Board

Pneuma Respiratory, Inc. announced that Board member Jay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman, Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation and...

Global market of dietary supplement is welcoming a rising star GLYMATE

Glymate(TM), a newly founded nutraceutical company in Southern California. Its proprietary sugar balance dietary supplement was officially announced in the United States in June 2019, marking the official launch of the global marketing of this product,...

Xinhua Silk Road: Tasly remains China#s 2019 National Tech Innovation Demonstration Enterprise

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent...

SweeGen#s non-GMO Reb M Stevia Leaf Sweetener Approved in Singapore

SweeGen, Inc., a nature-based sweetener company, announced the Singapore Food Agency has added SweeGen's Reb M Stevia Leaf Sweetener to the list of permitted food additives. SweeGen's Reb M is a non-caloric stevia sweetener that provides sweetness with...

Related Topics